Infusion of Some but Not All Types of Human Perinatal Stromal Cells Prevent Organ Fibrosis in a Humanized Graft versus Host Disease Murine Model

Allogeneic transplant rejection represents a medical complication that leads to high morbidity and mortality rates. There are no treatments to effectively prevent fibrosis; however, there is great interest in evaluating the use of perinatal mesenchymal stromal cells (MSCs) and other MSCs to prevent...

Descripción completa

Detalles Bibliográficos
Autores principales: Coronado, Ramon E., Stavenschi Toth, Elena, Somaraki-Cormier, Maria, Krishnegowda, Naveen, Dallo, Shatha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953740/
https://www.ncbi.nlm.nih.gov/pubmed/36830951
http://dx.doi.org/10.3390/biomedicines11020415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953740/
https://www.ncbi.nlm.nih.gov/pubmed/36830951
http://dx.doi.org/10.3390/biomedicines11020415

Ejemplares similares